Café Scientifique – Multiple Sclerosis: To B or not to B?

Listen in as specialists discuss new frontiers in MS research. Significant clinical benefit has been observed when immune cells called “B-lymphocytes” are eliminated in MS patients using immunotherapies. The team’s research goal is to unravel why this is the case. Join the ‘Café’ on Tuesday, February 18, 2014 from 7:30-9:30pm at 89 Chestnut Street, Toronto. RSVP by February 12 online or by email at angela.covert@mssociety.ca.